Prognostic value of sarcopenia in patients with CKD
- Autores: Sokolova A.V1, Dragunov D.O1, Arutyunov G.P1, Mitrokhin V.M1
-
Afiliações:
- Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
- Edição: Nº 1 (2019)
- Páginas: 48-55
- Seção: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273216
- DOI: https://doi.org/10.18565/nephrology.2019.148-55
- ID: 273216
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
A. Sokolova
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationPhD in Medical Sciences, Teaching Assistant at the Department of Propedeutics of Internal Diseases, Faculty of Pediatrics Moscow, Russia
D. Dragunov
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: tamops2211@gmail.com
PhD in Medical Sciences, Associate Professor at the Department of Propedeutics of Internal Diseases, Faculty of Pediatrics Moscow, Russia
G. Arutyunov
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationDoctor of Medical Sciences, Professor, Corresponding Member of RAS, Head of the Department of Propaedeutics of Internal Diseases of the Faculty of Pediatrics Moscow, Russia
V. Mitrokhin
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationPhD in Medical Sciences, Associate Professor at the Department of Propedeutics of Internal Diseases, Faculty of Pediatrics Moscow, Russia
Bibliografia
- Mahmood U, Healy H.G., Kark A., Cameron A., Wang Z., Abeysekera R., Hoy W.E. Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service. BMC. Nephrol. 2017; 18(1).
- Bellasi A, Mangano M., Galassi A., Cozzolino M. CKD-MBD, cardiovascular involvement and prognosis. NCBI. 2017; 34(69): 150-161.
- Hallan S.I., Orth S.R. The Conundrum of Chronic Kidney Disease Classification and End-Stage Renal Risk Prediction in the Elderly - What Is the Right Approach? Nephron. Clin. Pract. 2010; 116(4): 307-316.
- Kim J.-K. Choi S.R., Choi M.J., Kim S.G., Lee Y.K., Noh J.W., Kim H.J., Song Y.R. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin. Nutr. 2014; 33(1): 64-68. doi: 10.1016/j.clnu.2013.04.002
- Pereira R.A. Cordeiro A.C,Avesani C.M., Carrero J.J., Lindholm B.,Amparo F.C., Amodeo C., Cuppari L., Kamimura M.A. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol. Dial. Transplant. 2015; 30(10): 1718-1725. doi: 10.1093/ndt/gfv133.
- Han E., Lee Y.H., Kim G., Kim S.R., Lee B.W., Kang E.S., Ahn C.W., Cha B.S. Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008-2011. Metabolism. 2016; 65(10): 1531-1540. doi: 10.1016/j.metabol.2016.07.003.
- Fahal I.H. Uraemic sarcopenia: aetiology and implications. Nephrol. Dial. Transplant. 2014; 29(9): 1655-1665. doi: 10.1093/ndt/gft070.
- D’Alessandro C., Piccoli G.B., Barsotti M., Tassi S., Giannese D., Morganti R., Cupisti A. Prevalence and Correlates of Sarcopenia among Elderly CKD Outpatients on Tertiary Care. Nutrients. 2018; 10(12): 1951. doi: 10.3390/nu10121951.
- Арутюнов А.Т. и др. Влияние лекарственных форм петлевого диуретика с различной скоростью высвобождения на ранний и отсроченный прогноз у пациентов с декомпенсацией кровообращения. Кардиология. 2014; 9: 54.
- Hruska K.A., Choi E.T., Memon I., Davis T.K., Mathew S. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatr. Nephrol. 2010; 25(4): 769-778. doi: 10.1007/s00467-009-1337-0.
- Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N. Engl. J. Med. 2004; 351(13): 1296-1305. doi: 10.1056/NEJMoa041031.
- Rattanawong P. Kanitsoraphan C., Kewcharoen J., Riangwiwat T., Chongyangyuenvong P., Vutthikraivit W., Mannem S.R., Chung E.H. Chronic kidney disease is associated with increased mortality and procedural complications in transcatheter aortic valve replacement: a systematic review and meta-analysis. Catheter. Cardiovasc. Interv. 2019. doi: 10.1002/ccd.28102.
- Di Lullo L., House A, Gorini A., Santoboni A., Russo D., Ronco C. Chronic kidney disease and cardiovascular complications. Heart Fail. Rev. 2015; 20(3): 259-272,. doi: 10.1007/s10741-014-9460-9.
- Helena Oliveira Sa. A prevengao da Doenga Renal Cronica (DRC) ou A urgencia de uma politica nacional parao diagnostico e tratamento precoces. Port J. Nephrol. Hypert. 2013; (1): 9-12.
- Смирнов А.В., Шилов Е.М., Добронравов В.А., Каюков И.Т., Бобкова И.Н., Швецов М.Ю., Цыгин А.Н., Шутов А. М. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология. 2012; 1.
- Kidney International Supplements. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. ScienceDirect. com [Electronic resource]. URL: https://www.sciencedirect.com/journal/kidney-international-supplements/vol/3/issue/1 (accessed: 25.01.2018).
- Мареев В.Ю. et al. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Утверждены на Конгрессе ОССН 7 декабря 2012 года, на Правлении ОССН 31 марта 2013 и Конгрессе РКО 25 сентября 2013 года. Журнал сердечная недостаточность. 14; 7(81): 2013.
- Cruz-Jentoft A.J., Cruz-Jentoft A.J., Baeyens J.P, Bauer J.M., Boirie Y., Cederholm T., Landi F., Martin F.C., Michel J.P., Rolland Y., Schneider S.M., Topinkova E., Vandewoude M., Zamboni M. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4): 412-423. doi: 10.1093/ageing/afq034
- Rosenberg I.H. Sarcopenia: Origins and Clinical Relevance. J. Nutr. 1997; 127(5): 990S-991S.
- Foley R.N. et al. Kidney Function and Sarcopenia in the United States General Population: NHANES III. Am. J. Nephrol. 2007; 27(3): 279-286.
- Souza V.A. de et al. Sarcopenia in Chronic Kidney Disease. J. Bras. Nefrol. 2015; 37(1). doi: 10.5935/0101-2800.20150014.
- Moorthi R.N., Avin K.G. Clinical relevance of sarcopenia in chronic kidney disease: Curr. Opin. Nephrol. Hypertens. 2017; 26(3): 219-228. doi: 10.1097/MNH.0000000000000318.
- Zhou Y., Hellberg M., Svensson P., Hoglund P., Clyne N. Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5. Nephrol. Dial. Transplant. 2018; 33(2): 342-348. doi: 10.1093/ndt/gfw466.
- Dunlap W.A., Purnell W.D., McPherson S.D. A new synthetic absorbable suture for ophthalmic surgery: laboratory and clinical evaluation. South. Med. J. 1976; 69(5): 588-592.
- Su H., Lei C.-T., Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update Front. Immunol. 2017; 8.
- Pecoits-Filho R. et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 2003; 41(6): 1212-1218.
- Liang H., Xu F., Zhang T., Huang J., Guan Q., Wang H., Huang Q. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion. Biomed. Pharmacother. 2018; 106: 879-889. doi: 10.1016/j.biopha.2018.07.031.
- Wang S., Chen F., Yang S., Shi J. Interleukin-18: A Predictive Marker of Major Adverse Cardiovascular Events in Hemodialysis Patients. Int. Heart. J. 2018; 59(4): 786-790. doi: 10.1536/ihj.17-154.Formanowicz D., Wanic-Kossowska M., Pawliczak E., Radom M., Formanowicz P. Usefulness of serum interleukin-18 in predicting cardiovascular mortality in patients with chronic kidney disease - systems and clinical approach. Sci. Rep. 2016; 5(1). Doi: 10.1038/ srep18332.
- Hirai K., Ookawara S., Morishita Y. Sarcopenia and Physical Inactivity in Patients With Chronic Kidney Disease. Nephro-Urol. Mon. 2016; 8(3). doi: 10.5812/numonthly.37443.
- Derbre F. Gratas-Delamarche A., Gomez-Cabrera M.C., Vina J. Inactivity-induced oxidative stress: A central role in age-related sarcopenia? Eur. J. Sport Sci. 2014; 14(1): S98-S108. doi: 10.1080/17461391.2011.654268.
- Schaap L.A., Pluijm S.M., Deeg D.J., Harris T.B., Kritchevsky S.B., Newman A.B., Colbert L.H., Pahor M., Rubin S.M., Tylavsky F.A., Visser M. Higher Inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle Strength. J. Gerontol. A. Biol. Sci. Med. Sci. 2009; 64(11): 1183-1189. doi: 10.1093/gerona/glp097.
- Schaap L.A., Pluijm S.M., Deeg D.J., Visser M. Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength. Am. J. Med. 2006; 119(6): 526. e9-526.e17. doi: 10.1016/j.amjmed.2005.10.049.
- Honda H., Qureshi A.R., Axelsson J., Heimburger O., Suliman M.E., Barany P., Stenvinkel P., Lindholm B. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am. J. Clin. Nutr. 2007; 86(3): 633-638. doi: 10.1093/ajcn/86.3.633.
- Cesari M., Kritchevsky S.B., Baumgartner R.N., Atkinson H.H., Penninx B.W., Lenchik L., Palla S.L., Ambrosius W.T., Tracy R.P., Pahor M. Sarcopenia, obesity, and inflammation - results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am. J. Clin. Nutr. 2005; 82(2): 428-434. doi: 10.1093/ajcn.82.2.428.
- Bano G., Trevisan C., Carraro S., Solmi M., Luchini C., Stubbs B., Manzato E., Sergi G., Veronese N. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas. 2017; 96: 10-15. doi: 10.1016/j.maturitas.2016.11.006.
- Wright J., Hutchison A. Cardiovascular disease in patients with chronic kidney disease. Vasc. Health Risk Manag. 2009; 5: 713-722.
- Tesar V Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure. Vnitr. Lek. 2003; 49(5): 383-387.
- Lindholm B. et al. Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc. 1998; 13(6): 66-73.
- de Lusignan S., Chan T., Stevens P., O’Donoghue D., Hague N., Dzregah B., Van Vlymen J., Walker M., Hilton S. Identifying patients with chronic kidney disease from general practice computer records. Fam. Pract. 2005; 22(3): 234-241.
- Hanatani S. et al. Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease. Int. J. Cardiol. 2018; 268: 216-221. doi: 10.1016/j.ijcard.2018.03.064.